"Chlorisondamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.
Descriptor ID |
D002714
|
MeSH Number(s) |
D02.092.877.883.222 D02.675.276.200 D03.633.100.513.249
|
Concept/Terms |
Chlorisondamine Chloride- Chlorisondamine Chloride
- Chloride, Chlorisondamine
- Chlorisondamine Dichloride
- Dichloride, Chlorisondamine
|
Below are MeSH descriptors whose meaning is more general than "Chlorisondamine".
Below are MeSH descriptors whose meaning is more specific than "Chlorisondamine".
This graph shows the total number of publications written about "Chlorisondamine" by people in this website by year, and whether "Chlorisondamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Chlorisondamine" by people in Profiles.
-
Effects of prostaglandins and the autonomic nervous system on the vasodilatory properties of nitroglycerin in conscious dogs. J Cardiovasc Pharmacol. 1990 Sep; 16(3):417-22.
-
Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs. J Pharmacol Exp Ther. 1988 Aug; 246(2):591-6.
-
Role of isoflurane on hemodynamic properties and disposition of nicardipine. J Pharmacol Exp Ther. 1987 Jun; 241(3):899-906.
-
Uropharmacology: VII. Ganglionic stimulating and blocking agents. Urology. 1978 Apr; 11(4):425-31.
-
Effect of preganglionic nerve stimulation on sensitivity of the superior cervical ganglion to nicotinic blocking agents. Br J Pharmacol. 1974 Aug; 51(4):533-9.
-
Non-nicotinic transmission during ganglionic block with chlorisondamine and nicotine. Eur J Pharmacol. 1973 Oct; 24(1):78-85.